This is the authors' abstract. We don't add key points for this paper.
Previous literature suggests that maternal vancomycin crosses the placental barrier to the fetus. Further, early animal studies indicated that kidney injury was not observed in the progeny. These studies were conducted prior to the availability of sensitive biomarkers for kidney injury. Therefore, a previous finding of no renal damage to the infant may be misleading.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: